title: Recommendations for the incorporation of biomarkers into Alzheimer clinical trials: an overview.
authors.affiliation: Department of Neurology, Knight Alzheimer Disease Research Center, Washington University, St Louis, MO 63108, USA. morrisj@abraxas.wustl.edu
authors.forename: John C
authors.initials: JC
authors.lastname: Morris
authors.forename: Dennis J
authors.initials: DJ
authors.lastname: Selkoe
mesh_terms: D000544:Alzheimer Disease / Q000175:diagnosis* / Q000188:drug therapy*; D016229:Amyloid beta-Peptides / Q000032:analysis; D015415:Biomarkers / Q000032:analysis; D002986:Clinical Trials as Topic; D006801:Humans; D010506:Periodicals as Topic; D016875:tau Proteins / Q000032:analysis
chemical_list: D016229:Amyloid beta-Peptides; D015415:Biomarkers; D016875:tau Proteins